Recent studies have highlighted the alarming trend of antifungal resistance, which is becoming a critical issue in the management of invasive fungal infections. Research indicates that pathogenic ...

Invasive fungal infections (IFIs) pose a significant risk to patients with hematological malignancies, particularly those undergoing treatments like chemotherapy or hematopoietic cell transplantation.

For Cresemba, this comprises a milestone payment for sales in Canada, by AVIR Pharma Inc, as well as the first sales milestone payment for the Middle East and North Africa (MENA) region, by Hikma ...

Anti-Fungal Therapy Market. The global anti-fungal therapy market is set to experience significant growth, with a projected ...

Recent findings indicate that the new BTK inhibitors, although not targeting TEC kinases, may be responsible for fungal infections via a disruption of the signal downstream of BTK, responsible for ...

Invasive fungal infections are a major problem in solid organ transplant (SOT) recipients. Overall, the most common fungal infection in SOT is candidiasis, followed by aspergillosis and ...

NY suddenly started withholding names of medical facilities with cases of deadly drug-resistant fungus Candida auris. We got ...

Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial ...

Fungal infections, such as athlete’s foot and ringworm, occur when one type of fungal microbe becomes too prevalent in one area of the body so that the immune system cannot defeat it.

UK biotech F2G has raised $100 million as it prepares to refile its olorofim candidate for invasive fungal infections, which was turned down last year by the FDA. The Manchester-based company said ...